BioNTech Operating Income from 2010 to 2024
| 0A3M Stock | USD 110.25 4.06 3.55% |
Operating Income | First Reported 2010-12-31 | Previous Quarter 904.2 M | Current Value 859 M | Quarterly Volatility 4.9 B |
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Other Operating Expenses of 385.3 M or EBIT of 14.4 B, as well as many indicators such as . BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
BioNTech | Operating Income |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of BioNTech Correlation against competitors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.